{"id":181,"date":"2023-04-13T11:46:58","date_gmt":"2023-04-13T09:46:58","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/entreprise\/histoire\/"},"modified":"2025-11-26T13:13:05","modified_gmt":"2025-11-26T11:13:05","slug":"histoire","status":"publish","type":"page","link":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/","title":{"rendered":"Notre Histoire"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/30085710\/Company-History.jpg)\">\n        <div class=\"container content-sec\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\">Accueil<\/a><\/li><li class=\"breadcrumb-item visible\"><a href=\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/\">Entreprise<\/a><\/li><li class=\"breadcrumb-item active\"><a class=\"link-pointer-events-none\" href=\"#\" aria-current=\"page\">Notre Histoire<\/a><\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Notre Histoire<\/h1>\n            <p class=\"visible\"> Plus de 95 ans d\u2019expertise dans des aires th\u00e9rapeutiques avec d\u2019importants besoins m\u00e9dicaux non satisfaits.<\/p>\n        <\/div>\n    <\/section>\n\n\n    <section class=\"title-text \">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-color:#EDEBE4;\">\n\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash hidden\">\n                <h3 class=\"heading-three\" role=\"heading\" aria-level=\"2\">\n                                            <\/h3>\n                <\/div>\n               \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p>Fond\u00e9e en 1929 en tant qu&rsquo;entreprise familiale, Ipsen dispose de pr\u00e8s d&rsquo;un si\u00e8cle\u00a0d&rsquo;exp\u00e9rience et d&rsquo;expertise. Le Groupe se focalise aujourd&rsquo;hui sur trois aires th\u00e9rapeutiques :\u00a0l&rsquo;oncologie, les maladies rares et les neurosciences.<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                                        <div class=\"btn-txt\">\n                            <a \n                                aria-label=\"\" \n                                class=\"btn-link section-btn cta-visible\"  \n                                role=\"link\"\n                                href=\"\/fr\/entreprise\/\" target=\"_blank\">\n                                En savoir plus                            <\/a>\n                        <\/div>\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n\u00a0\n<!-- Ipsen History Timeline Start -->\n<section class=\"history-pipeline\" >\n\t<div class=\"container\">\n  \t\t<h3 class=\"history-title heading-three\">\n\t\t\tLes \u00e9tapes importantes de l&#039;histoire d&#039;Ipsen\t\t<\/h3>\n  \t\t\t\t\t<input type=\"hidden\" class=\"pagenum\" value=\"1\" \/>\n\t\t\t<input type=\"hidden\" class=\"total-page\" id=\"total_page\" value=\"18\" \/>\n\t\t\t<input type=\"hidden\" class=\"post_id\" id=\"post_id\" value=\"181\" \/>\n\t\t\t<input type=\"hidden\" class=\"tot_load_post\" id=\"tot_load_post\" value=\"\" \/>\n\t\t\t<input type=\"hidden\" class=\"start_inn\" id=\"start_inn\" value=\"5\" \/>\n\t\t\t\t  \t\t\t<div class=\"timeline-filter\">\n\t  \t\t\tP\u00e9riode \n\t\t\t\t<select aria-label=\"period\" name=\"period\" id=\"period\" onChange=\"getyears()\" tabindex=\"0\">\t\t\t\t\t\t\t\t\n\t\t\t\t\t<option value=\"all\">Tout voir<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<option value=\"2023\">2023<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2022\">2022<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2019\">2019<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2016\">2016<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2015\">2015<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2013\">2013<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2011\">2011<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2005\">2005<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2004\">2004<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2003\">2003<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"2000\">2000<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1990\">1990<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1980\">1980<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1970\">1970<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1960\">1960<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1950\">1950<\/option>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<option value=\"1929\">1929<\/option>\n\t\t\t\t\t\t\t\t\t\t\t<\/select>\n  \t\t\t<\/div>\n  \t\t  \t\t<div id=\"loading\"\n\t\t  style=\"background-image: url('https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/loader.png');z-index: 9999;display: none;position: absolute;left: 50%;\">\n\t  \t<\/div>\n\t\t<div class=\"main-timeline\">\t\n   \t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-right\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5>Mars  2023 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline left-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/05\/13115159\/01-C_March-2023_Ipsen-acquires-Albireo_1.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Ipsen acquiert Albireo<\/strong><\/p>\n<p>Ipsen acquiert Albireo, une entreprise sp\u00e9cialis\u00e9e dans les maladies rares du foie, et int\u00e8gre ainsi \u00e0 son portefeuille Bylvay\u00ae (odevixibat), un inhibiteur non syst\u00e9mique du transport il\u00e9al des acides biliaires pour le traitement du prurit chez l&rsquo;enfant atteint de la cholestase intrah\u00e9patique familiale progressive (PFIC).<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-left\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5>Ao\u00fbt  2022 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline right-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/11\/14070306\/01-C_August-2022_Epizyme_acquired.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Acquisition d&rsquo;Epizyme<\/strong><\/p>\n<p>Ipsen finalise l&rsquo;acquisition d&rsquo;Epizyme et de son m\u00e9dicament phare, Tazverik\u00ae (tazemetostat), un inhibiteur d\u2019EZH2 sans chimioth\u00e9rapie, premier de sa cat\u00e9gorie, pour les adultes atteints d\u2019un lymphome folliculaire (FL) r\u00e9cidivant ou r\u00e9fractaire. Tazverik obtient l\u2019approbation acc\u00e9l\u00e9r\u00e9e des autorit\u00e9s am\u00e9ricaines (FDA) en 2020. Dans le cadre de la transaction, Ipsen acquiert \u00e9galement l\u2019inhibiteur oral de SETD2 d\u2019Epizyme, candidat-m\u00e9dicament premier de sa cat\u00e9gorie en cours de d\u00e9veloppement.<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-right\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5>Juillet  2022 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline left-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/05\/13115158\/01-C_July-2022_Consumer-HealthCare-divested.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Cession de l&rsquo;activit\u00e9 Sant\u00e9 Familiale<\/strong><\/p>\n<p>En f\u00e9vrier 2022, Ipsen annonce le projet de vente de sa division Sant\u00e9 Familiale apr\u00e8s \u00eatre entr\u00e9 en n\u00e9gociations exclusives avec le laboratoire fran\u00e7ais Mayoly Spindler. En juillet, Ipsen finalise la cession de son activit\u00e9 Sant\u00e9 Familiale \u00e0 Mayoly Spindler.<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-left\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5> 2019 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline right-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/11\/14070711\/01-C_2019_Boosting-Ipsen-s-capacities-in-Rare-Disease.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Renforcer les capacit\u00e9s d&rsquo;Ipsen dans les Maladies Rares<\/strong><\/p>\n<p>Ipsen acquiert Ia soci\u00e9t\u00e9 montr\u00e9alaise Clementia Pharmaceuticals, sp\u00e9cialis\u00e9e dans les maladies osseuses rares, qui apporte \u00e0 Ipsen un candidat-m\u00e9dicament, le palovarot\u00e8ne, pour le traitement de la fibrodysplasie ossifiante progressive (FOP), une maladie g\u00e9n\u00e9tique rare.<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t<div>\n\t\t\t<div class=\"custom-year-right\"  >\n\t\t\t<i class=\"far fa-clock\" aria-hidden=\"true\"><\/i> \n\t\t\t\t\t<h5> 2016 <\/h5>\n\t\t\t<\/div>\n\t\t\t<div class=\"timeline left-2\">\n\t\t\t\t<div class=\"card-history\">\n\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/11\/26130230\/01-C_2019_Treatment-approvals-and-asset-acquisitions.jpeg\" class=\"card-img-top\" alt=\"\">\n\t\t\t\t\t\t\t\t<div class=\"card-body\">                   \n\t\t\t\t\t<div class=\"mb-0\"><p><p><strong>Approbations de traitement et acquisitions d&rsquo;actifs<\/strong><\/p>\n<p>L&rsquo;injection de Dysport est approuv\u00e9e aux \u00c9tats-Unis pour le traitement de la spasticit\u00e9 des membres inf\u00e9rieurs chez l&rsquo;enfant \u00e2g\u00e9 de deux ans et plus. Ipsen signe \u00e9galement un accord de licence avec Exelixis pour le cabozantinib, qui re\u00e7oit la m\u00eame ann\u00e9e l&rsquo;autorisation de mise sur le march\u00e9 pour le traitement en deuxi\u00e8me ligne du carcinome du rein avanc\u00e9. En janvier de l&rsquo;ann\u00e9e suivante, Ipsen annonce l&rsquo;acquisition de certains actifs de Merrimack Pharmaceuticals, dont Onivyde\u00ae, pour le traitement des cancers du pancr\u00e9as et des ovaires.<\/p>\n<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>              \n\t\t\t<\/div>        \n\t\t<\/div>\n\t\t\t\t\t\n\t<\/div>\t\n\t\t\t\t\t<div class=\"loader-more\" style=\"text-align:center\" onClick=\"getresult()\">\n\t\t\tFaites d\u00e9filer pour charger plus\t\t\t<img decoding=\"async\" class=\"loader-img\" src=\"https:\/\/d3glparxwv1yl3.cloudfront.net\/wp-content\/themes\/ipsen-main\/dist\/images\/loader.png\" alt=\"loader\" title=\"loader\">\n\t\t<\/div>\n\t\t   <\/div>\n<\/section>\n<!-- Ipsen History Timeline End -->\n\n\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":177,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-181","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notre Histoire - Global<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notre Histoire - Global\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-26T11:13:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/\",\"name\":\"Notre Histoire - Global\",\"isPartOf\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website\"},\"datePublished\":\"2023-04-13T09:46:58+00:00\",\"dateModified\":\"2025-11-26T11:13:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entreprise\",\"item\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Notre Histoire\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notre Histoire - Global","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Notre Histoire - Global","og_url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/","og_site_name":"Global","article_modified_time":"2025-11-26T11:13:05+00:00","twitter_card":"summary_large_image","twitter_site":"@ipsengroup","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/","name":"Notre Histoire - Global","isPartOf":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website"},"datePublished":"2023-04-13T09:46:58+00:00","dateModified":"2025-11-26T11:13:05+00:00","breadcrumb":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/histoire\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/"},{"@type":"ListItem","position":2,"name":"Entreprise","item":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/entreprise\/"},{"@type":"ListItem","position":3,"name":"Notre Histoire"}]},{"@type":"WebSite","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#website","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#organization","name":"IPSEN","url":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2025\/06\/13064320\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages\/181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/comments?post=181"}],"version-history":[{"count":56,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages\/181\/revisions"}],"predecessor-version":[{"id":70739,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages\/181\/revisions\/70739"}],"up":[{"embeddable":true,"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/pages\/177"}],"wp:attachment":[{"href":"https:\/\/d3glparxwv1yl3.cloudfront.net\/fr\/wp-json\/wp\/v2\/media?parent=181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}